---
category: trading
circular_id: c29447d20ac2e479
date: '2025-08-21'
description: BSE announces revised settlement dates for the acquisition window takeover
  offer of Pharmaids Pharmaceuticals Limited, extending settlement to August 25, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={9242081B-5F9C-4544-802E-04E72A83397D}&noticeno=20250821-1&dt=08/21/2025&icount=1&totcount=28&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Settlement schedule revision affects specific takeover participants
  but has limited broader market impact
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20250821-1&attachedId=
processing:
  attempts: 1
  content_hash: a160cbb6b66740d0
  processed_at: '2025-08-21T12:47:47.608529'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-08-21T06:20:03+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={9242081B-5F9C-4544-802E-04E72A83397D}&noticeno=20250821-1&dt=08/21/2025&icount=1&totcount=28&flag=0
severity: medium
source: bse
stocks:
- PHARMAIDS
tags:
- takeover
- settlement
- pharmaids-pharmaceuticals
- acquisition
- revised-schedule
title: Revised Settlement Schedule for Pharmaids Pharmaceuticals Limited Takeover
  Offer
---

## Summary

BSE has revised the settlement schedule for the Offer to Buy - Acquisition Window (Takeover) for Pharmaids Pharmaceuticals Limited. The takeover offer period ran from August 4-18, 2025, with revised obligation download date of August 22, 2025 and settlement date of August 25, 2025.

## Key Points

- Settlement Type: Takeover (Settlement No. 2025067)
- Bid period: August 4-18, 2025 (completed)
- Revised obligation download: August 22, 2025
- Revised settlement date: August 25, 2025
- Demat shares must be delivered through Early Pay-in mechanism
- Market Type "Takeover" and settlement No. 2025035 to be used in depository system

## Regulatory Changes

No new regulatory changes introduced. This circular provides revised settlement timeline following existing takeover acquisition guidelines.

## Compliance Requirements

- Members/Custodians must use Early Pay-in of Shares mechanism for demat share delivery
- Must specify Market Type "Takeover" and settlement No. 2025035 in depository system
- Members should refer to MBRSTD_OTB_CM_mmm_SettNo file for client-wise stamp duty charges
- Compliance with Revised Guidelines for acquisition of shares through Stock Exchange (Notice No. 20200528-32)

## Important Dates

- **August 22, 2025**: Revised Obligation Download Date
- **August 25, 2025**: Revised Settlement Date
- Original takeover offer period: August 4-18, 2025 (completed)

## Impact Assessment

Limited impact as this affects only participants in the specific Pharmaids Pharmaceuticals takeover offer. The revision provides additional time for settlement obligations, ensuring proper completion of the acquisition process. No broader market implications expected.